Medicine
Actos 15 mg tablet
Actos 15 mg tablet is a prescription medicine containing Pioglitazone for oral use, marketed by Takeda Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15-30°C (59-86°F). Keep…
Key facts
- Active ingredient (INN)
- Pioglitazone
- Brand
- Actos
- Strength
- 15 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 6 cartons, 30 tablets, 90 tablets and 1 more
- Marketing authorisation holder
- Takeda Pharmaceuticals
- Manufacturer
- Takeda Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15-30°C (59-86°F). Keep container tightly closed, and protect from light, moisture and humidity.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A10BG03 Pioglitazone
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 July 1999
- Identifiers
- RxCUI 261266, 261267, 261268 +3DailyMed set ID d2ddc491-88a9-4063-9150-443b4fa4330cNDC 64764-151Application NDA021073
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 6 carton in 1 tray / 1 blister pack in 1 carton / 7 tablet in 1 blister pack | 64764-151-02 | Takeda Pharmaceuticals | 15 July 1999 |
| 30 tablet in 1 bottle | 64764-151-04 | Takeda Pharmaceuticals | 15 July 1999 |
| 90 tablet in 1 bottle | 64764-151-05 | Takeda Pharmaceuticals | 15 July 1999 |
| 500 tablet in 1 bottle | 64764-151-06 | Takeda Pharmaceuticals | 15 July 1999 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Pioglitazone 15 mg tablet.
Other strengths and forms of Pioglitazone
Clinical summary
Pioglitazone is a peroxisome proliferator receptor alpha agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings. MedsAcross supplies Pioglitazone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PioglitazoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Actos prescribing information (Takeda Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Actos: European public assessment report (EPAR) · European Medicines Agency
- Pioglitazone Accord: European public assessment report (EPAR) · European Medicines Agency
Need Actos 15 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.